المؤلفون: Trunfio, Mattia^{Aff1, Aff2, IDs1046102404440w_cor1}, Vuaran, Elisa, Vai, Daniela, Quarta, Caterina, Di Stefano, Alessandro, Imperiale, Daniele, Cinnirella, Giacoma, Bonora, Stefano, Di Perri, Giovanni, Letendre, Scott L., Calcagno, Andrea

المصدر: AIDS and Behavior. :1-12

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Scabini, Silvia, Trunfio, Mattia, Pirriatore, Veronica, Imperiale, Daniele, Audagnotto, Sabrina, Bertucci, Roberto, Ghisetti, Valeria, Cinnirella, Giacoma, Cistaro, Angelina, Perna, Mariaelena, Calcagno, Andrea, Di Perri, Giovanni

المصدر: Infezioni in Medicina; 2018, Vol. 26 Issue 2, p160-163, 4p

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: D’avolio, Antonio, Peila, Emanuela, Simiele, Marco, Pensi, Debora, Baietto, Lorena, Cusato, Jessica, Cinnirella, Giacoma, De Rosa, Francesco, Di Perri, Giovanni

المصدر: Therapeutic Drug Monitoring; Dec2013, Vol. 35 Issue 6, p853-858, 6p

المؤلفون: Sciascia S; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy., Aprà F; ASL Città di Torino, Italy., Baffa A; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy., Baldovino S; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy., Boaro D; ASL Città di Torino, Italy., Boero R; ASL Città di Torino, Italy., Bonora S; ASL Città di Torino, Italy., Calcagno A; ASL Città di Torino, Italy., Cecchi I; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy., Cinnirella G; ASL Città di Torino, Italy., Converso M; ASL Città di Torino, Italy., Cozzi M; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy., Crosasso P; ASL Città di Torino, Italy., De Iaco F; ASL Città di Torino, Italy., Di Perri G; ASL Città di Torino, Italy., Eandi M; ASL Città di Torino, Italy., Fenoglio R; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy., Giusti M; ASL Città di Torino, Italy., Imperiale D; ASL Città di Torino, Italy., Imperiale G; ASL Città di Torino, Italy., Livigni S; ASL Città di Torino, Italy., Manno E; ASL Città di Torino, Italy., Massara C; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy., Milone V; ASL Città di Torino, Italy., Natale G; ASL Città di Torino, Italy., Navarra M; ASL Città di Torino, Italy., Oddone V; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy., Osella S; ASL Città di Torino, Italy., Piccioni P; ASL Città di Torino, Italy., Radin M; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy., Roccatello D; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy. dario.roccatello@unito.it., Rossi D; CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy.

المصدر: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2020 May-Jun; Vol. 38 (3), pp. 529-532. Date of Electronic Publication: 2020 May 01.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Clinical And Experimental Rheumatology S.A.S Country of Publication: Italy NLM ID: 8308521 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0392-856X (Print) Linking ISSN: 0392856X NLM ISO Abbreviation: Clin Exp Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Betacoronavirus*, Antibodies, Monoclonal, Humanized/*therapeutic use , Coronavirus Infections/*therapy , Pneumonia, Viral/*therapy, Aged ; COVID-19 ; Female ; Humans ; Male ; Middle Aged ; Off-Label Use ; Pandemics ; Pilot Projects ; Prospective Studies ; Receptors, Interleukin-6/antagonists & inhibitors ; SARS-CoV-2 ; Treatment Outcome

المؤلفون: Scabini S; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Italy., Trunfio M; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Italy., Pirriatore V; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Italy., Imperiale D; Department of Neurology, Maria Vittoria Hospital, ASLTO2, Torino, Italy., Audagnotto S; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Italy., Bertucci R; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Italy., Ghisetti V; Laboratory of Microbiology and Molecular Biology, Amedeo di Savoia Hospital, ASLTO2, Torino, Italy., Cinnirella G; Hospital pharmacy, Amedeo di Savoia Hospital, ASLTO2, Torino, Italy., Cistaro A; Positron Emission Tomography Centre IRMET, Affidea, Torino, Italy, Neuroimaging Steering Committee of AIMN, Italy., Perna M; Department of Radiology, Giovanni Bosco Hospital, ASLTO2, Torino, Italy., Calcagno A; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Italy., Di Perri G; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Italy.

المصدر: Le infezioni in medicina [Infez Med] 2018 Jun 01; Vol. 26 (2), pp. 160-163.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Edizioni Internazionali srl Country of Publication: Italy NLM ID: 9613961 Publication Model: Print Cited Medium: Internet ISSN: 2532-8689 (Electronic) Linking ISSN: 11249390 NLM ISO Abbreviation: Infez Med Subsets: MEDLINE

مواضيع طبية MeSH: CCR5 Receptor Antagonists/*administration & dosage , Leukoencephalopathy, Progressive Multifocal/*drug therapy , Maraviroc/*administration & dosage , Mirtazapine/*administration & dosage, Drug Therapy, Combination ; Female ; HIV Seronegativity ; Humans ; Middle Aged